Actively Recruiting
Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-03-21
20
Participants Needed
2
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Social cognition, which refers to the ability to interpret social information and behave accordingly in a social environment, is crucial in everyday life. But this ability has been shown to be altered in patients with epilepsy, especially in medial temporal lobe epilepsy, which leads to a deterioration in the patient's quality of life. However, the mechanisms of those deficiencies remain largely unknown. The Team objective is to achieve a structural and functional cartography of the social cognition network in 20 healthy subjects and 20 patients with drug-resistant medial temporal lobe epilepsy (before and one year after resective surgery of the epileptogenic focus). Social cognition deficiencies will be assessed using a specifically dedicated neuropsychological assessment validated in French (Batteries de Cognition Sociale BCS). Brain structural analyses will be performed on a 3-Tesla MRI (3T MRI), including an anatomical T1 sequence, a High Angular Resolution Diffusion Imaging (HARDI) to assess the morphology and macrostructural characteristics of long and short white matter tracts involved in social cognition, and quantitative MRI and Hybrid Diffusion Imaging (HYDI) to assess their microstructure. Functional connectivity will be assessed using an ultra-high-field 7-Tesla MRI (7T MRI), with acquisition in resting state and during specific social cognition tasks. Joint analysis of structural and functional connectivity will enable the team to assess the alterations of social cognition networks in patients with epilepsy and their reorganisations after epilepsy surgery.
CONDITIONS
Official Title
Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Good understanding of written and verbal French language
- Signed written consent by the participant
- Diagnosis of focal temporal lobe epilepsy with hippocampal sclerosis for at least one year and drug-resistant
- Currently undergoing presurgical assessment
- Affiliated with a social security system
You will not qualify if you...
- Under legal protection
- Claustrophobia or any contraindication to MRI
- Pregnant or lactating
- Participating in another research study with an exclusion period
- Refusal to be informed if anomalies are found during MRI scans
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
NeuroSpin - CEA
Gif-sur-Yvette, France, 91191
Active, Not Recruiting
2
Unité d'épilepsie - GHU Pitié Salpêtrière
Paris, France, 75013
Actively Recruiting
Research Team
B
Bastien HERLIN, MD, PH
CONTACT
S
Sophie DUPONT, MD,PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here